Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder. (2014)
Attributed to:
MRC Centre for Neuropsychiatric Genetics and Genomics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1318810111
PubMed Identifier: 24711425
Publication URI: http://europepmc.org/abstract/MED/24711425
Type: Journal Article/Review
Volume: 111
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 16
ISSN: 0027-8424